Finance

Lists
NWBO:OTCMKTS
Northwest Biotherapeutics Inc
0,16 $
-1,53%
(-0,0025) 1D
14 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NWBO...
Open
0,16 $
High
0,17 $
Low
0,16 $
Mkt. cap
277,15 млн
Avg. vol.
3,89 млн
Volume
5,33 млн
52-wk high
0,34 $
52-wk low
0,14 $
EPS
-0,03 $
Beta
-0,62
Shares outstanding
1,71 млрд
No. of employees
105
Open
0,16 $
High
0,17 $
Low
0,16 $
Mkt. cap
277,15 млн
Avg. vol.
3,89 млн
Volume
5,33 млн
52-wk high
0,34 $
52-wk low
0,14 $
EPS
-0,03 $
Beta
-0,62
Shares outstanding
1,71 млрд
No. of employees
105
News stories
From web sources and news partners
Profile
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
About Northwest Biotherapeutics Inc
CEO-
Employees105
Founded1998 ж. 01 қаң.
Headquarters-
Sector-
Websitenwbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
200,00 м.
672,00 м.
494,00 м.
807,00 м.
Cost of goods sold
7,45 млн
5,55 млн
4,86 млн
5,70 млн
Cost of revenue
7,45 млн
5,55 млн
4,86 млн
5,70 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,07 млн
8,62 млн
6,54 млн
6,71 млн
Operating expense
7,07 млн
8,62 млн
6,54 млн
6,71 млн
Total operating expenses
14,52 млн
14,18 млн
11,39 млн
12,41 млн
Operating income
-14,32 млн
-13,50 млн
-10,90 млн
-11,60 млн
Other non operating income
-3,45 млн
1,14 млн
9,53 млн
64,00 мың
EBT including unusual items
-26,83 млн
851,00 м.
-3,07 млн
-9,22 млн
EBT excluding unusual items
-21,20 млн
-14,82 млн
-5,06 млн
-13,47 млн
Income tax expense
-
-537,00 м.
-
-
Effective tax rate
-
-63,10%
-
-
Other operating expenses
-
-
-
-
Net income
-26,83 млн
1,39 млн
-3,07 млн
-9,22 млн
Net profit margin
-13 414,50%
206,55%
-621,25%
-1 142,63%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2,62 млн
-2,65 млн
-2,35 млн
-1,81 млн
Net interest expenses
-2,62 млн
-2,65 млн
-2,35 млн
-1,81 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-13,87 млн
-12,78 млн
-10,13 млн
-10,83 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары